Atrial Fibrillation

A study using ultra-high-density mapping of post-ablation atrial arrhythmias teaches us that over one-third of patients who present with an atrial tachycardia that demonstrates an isoelectric period actually have a macroreentrant mechanism.

Dr Hany Demo outlines his initial experience with zero-fluoroscopy pulsed field ablation for atrial fibrillation, focusing on patient selection, procedural workflow, and practical tips for incorporating this technique into clinical practice.

EP Lab Digest talks with Till Althoff, MD, about implementation of a streamlined same-day discharge (SDD) program after atrial fibrillation ablation, including development of a standardized protocol and creation of a dedicated SDD coordinator.

In September 2024, the first sham-controlled AF ablation trial was published simultaneous with presentation of the study findings at the European Society of Cardiology (ESC) Congress 2024.

EP Lab Digest talks with Benjamin A Steinberg, MD, MHS, FHRS, about findings and implications of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.

Historically, more resources, attention, and personnel are dedicated to the cardiac operating rooms, cardiac intensive care units, and catheterization laboratories than to the EP laboratories. There are many reasons why.

Sunthosh V Parvathaneni, MD, FACC, FHRS, and Dante A Dali, DO, FACS, present a case illustrating a successful hybrid Convergent approach.

As computer science has enjoyed groundbreaking advances that have transformed other sectors of society, the idea of its application in medicine has generated excitement over its potential to fill knowledge gaps.

In this interview from Western AF 2024, we speak with Suneet Mittal, MD, from the Valley Health System on what it takes to move atrial fibrillation (AF) practice to the outpatient setting.